GlaxoSmithKline and Impax partner on Parkinson's drug
Links shared publicly online about this topic.
- 648total visits
GlaxoSmithKline and Impax partner on Parkinson's drug
View full resource at zenopa.com
Tags: Parkinson's Disease, Drug, GlaxoSmithKline
Most Recently Shared on December 17, 2010 at 5:53 pm By:
GlaxoSmithKline and Impax partner on Parkinson's drug http://bit.ly/hVp5TU
Impax, GlaxoSmithKline report top-line results from phase 3 Parkinson's disease trial - Proactiveinvestors (NA)
proactiveinvestors.com — “Drug maker Impax Laboratories (NASDAQ:IPXL) and healthcare giant GlaxoSmithKline (NYSE:GSK) reported Monday they met their primary goal of a phase three clinical trial for a Parkinson's disease drug.” View full resource at proactiveinvestors.com
Most Recently Shared on August 16, 2011 at 7:45 pm By:
BGS MDSection Health Organization
IPX066 (new extended release carbidopa-levodopa) reduced off time more than carbidopa-levodopa-entacapone in... http://t.co/FEJnprw
GlaxoSmithKline Reports Positive Results From Second Parkinson's Drug Trial | ThirdAge
thirdage.com — “GlaxoSmithKline has said a second study for a reformulated Parkinson's treatment partnered with Impax Laboratories has produced positive results.” View full resource at thirdage.com
Most Recently Shared on August 15, 2011 at 7:18 pm By:
GlaxoSmithKline Reports Positive Results From Second Parkinson's Drug Trial http://t.co/sbuObp2
GSK, partner Impax plan 4Q NDA for new Parkinson’s drug
medcitynews.com — “GlaxoSmithKline and partner Impax will soon submit a new drug application for a Parkinson's disease treatment. Read more about what the drug does.” View full resource at medcitynews.com
Most Recently Shared on August 15, 2011 at 6:54 pm By:
GSK, partner Impax plan 4Q NDA for new Parkinson’s drug http://t.co/h0BhC1Z
UPDATE 1-Glaxo buys rights to Parkinson's drug from Impax | Reuters
reuters.com — “* Impax gets $11.5 mln upfront, up to $175 mln in milestones * Extended release drug IPX066 in Phase III trials (Adds detail, background) LONDON, Dec 16 (Reuters) - GlaxoSmithKline ” View full resource at reuters.com
Most Recently Shared on December 16, 2010 at 2:22 pm By:
John Carroll Health Communicator
Impax will get $11.5M upfront and up to $175M in milestones from GSK on Parkinson's drug pact. http://reut.rs/eTqKgG
Advertisement
